{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:09:36Z","timestamp":1790662176954,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hfc.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:50:00Z","timestamp":1742233800000},"page":"201-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Coronary Microvascular Dysfunction"],"prefix":"10.1016","volume":"21","author":[{"given":"Marcelo F.","family":"Di Carli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.hfc.2025.01.002_bib1","first-page":"e368","article-title":"AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2025.01.002_bib2","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.CIR.95.2.522","article-title":"Coronary microcirculation in health and disease. Summary of an NHLBI workshop","volume":"95","author":"Chilian","year":"1997","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.hfc.2025.01.002_bib4","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.hfc.2025.01.002_bib5","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1161\/hc4501.099316","article-title":"Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but \"Normal\" coronary angiography","volume":"104","author":"De Bruyne","year":"2001","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.hfc.2025.01.002_bib6","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.101.16.1931","article-title":"Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography","volume":"101","author":"Gould","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2025.01.002_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"issue":"24","key":"10.1016\/j.hfc.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.117.029992","article-title":"Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease","volume":"136","author":"Gupta","year":"2017","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.hfc.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2025.01.002_bib10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jcmg.2022.03.032","article-title":"Association of sex, reduced myocardial flow reserve, and long-term mortality across spectrum of atherosclerotic disease","volume":"15","author":"Patel","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.114.009716","article-title":"Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jacc.2011.01.065","article-title":"Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia","volume":"58","author":"Ziadi","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2025.01.002_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006427","article-title":"Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging","volume":"10","author":"Feher","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcmg.2021.11.022","article-title":"Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction","volume":"15","author":"Arnold","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.hfc.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jcmg.2010.07.008","article-title":"Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study","volume":"3","author":"Doyle","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib16","article-title":"Incremental value of transthoracic Doppler echocardiography-assessed coronary flow reserve in patients with suspected myocardial ischemia undergoing myocardial perfusion scintigraphy","volume":"6","author":"Gan","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","article-title":"Coronary microvascular dysfunction in hypertrophy and heart failure","volume":"116","author":"Camici","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"20","key":"10.1016\/j.hfc.2025.01.002_bib18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM198811173192002","article-title":"Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy","volume":"319","author":"Brush","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"35","key":"10.1016\/j.hfc.2025.01.002_bib19","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1093\/eurheartj\/ehab610","article-title":"Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease","volume":"43","author":"Brown","year":"2022","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.hfc.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.123.067083","article-title":"Relationship of subendocardial perfusion to myocardial injury, cardiac structure, and clinical outcomes among patients with hypertension","volume":"150","author":"Xu","year":"2024","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2025.01.002_bib21","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/eurheartj\/ehaa191","article-title":"Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure","volume":"41","author":"Zhou","year":"2020","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.hfc.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1161\/01.CIR.0000074211.28917.31","article-title":"Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis","volume":"107","author":"Rajappan","year":"2003","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.hfc.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis: a disease of the valve and the myocardium","volume":"60","author":"Dweck","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2025.01.002_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamacardio.2021.3396","article-title":"Association of myocardial blood flow reserve with adverse left ventricular remodeling in patients with aortic stenosis: the microvascular disease in aortic stenosis (MIDAS) study","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","article-title":"Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy","volume":"6","author":"Bravo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.hfc.2025.01.002_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.75.6.1130","article-title":"Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy","volume":"75","author":"Tanaka","year":"1987","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacc.2005.10.062","article-title":"Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function","volume":"47","author":"Schindler","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","article-title":"Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease","volume":"24","author":"Tona","year":"2014","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.hfc.2025.01.002_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jacc.2018.05.049","article-title":"Coronary microvascular dysfunction and cardiovascular risk in obese patients","volume":"72","author":"Bajaj","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2025.01.002_bib31","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","article-title":"Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events","volume":"57","author":"Peters","year":"2014","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.hfc.2025.01.002_bib32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2967\/jnumed.110.082883","article-title":"Coronary circulatory function in patients with the metabolic syndrome","volume":"52","author":"Di Carli","year":"2011","journal-title":"J\u00a0Nucl med"},{"issue":"8","key":"10.1016\/j.hfc.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib34","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0735-1097(97)00327-6","article-title":"Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus","volume":"30","author":"Yokoyama","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.hfc.2025.01.002_bib35","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.hfc.2025.01.002_bib36","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.jacc.2017.09.1104","article-title":"Coronary microvascular dysfunction identifies patients at high risk of adverse events across cardiometabolic diseases","volume":"70","author":"Osborne","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2025.01.002_bib37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"issue":"37","key":"10.1016\/j.hfc.2025.01.002_bib38","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.hfc.2025.01.002_bib39","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1161\/CIRCULATIONAHA.110.009928","article-title":"Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study","volume":"123","author":"Everett","year":"2011","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.hfc.2025.01.002_bib40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2025.01.002_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.119.043916","article-title":"Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in patients with chronic kidney impairment","volume":"141","author":"Bajaj","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.ki.5000031","article-title":"Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease","volume":"69","author":"Chade","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.kint.2017.07.025","article-title":"Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage","volume":"93","author":"Charytan","year":"2018","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.hfc.2025.01.002_bib44","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ehjci\/jev012","article-title":"Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes","volume":"16","author":"Majmudar","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/hc0202.102119","article-title":"Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction","volume":"105","author":"Neglia","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"24","key":"10.1016\/j.hfc.2025.01.002_bib47","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of takotsubo syndrome","volume":"135","author":"Pelliccia","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2025.01.002_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hfc.2025.01.002_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.012208","article-title":"Association between impaired myocardial flow reserve on (82)Rubidium positron emission tomography imaging and adverse events in patients with autoimmune rheumatic disease","volume":"14","author":"Feher","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.hfc.2025.01.002_bib50","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jcmg.2020.12.031","article-title":"Impaired coronary vasodilator reserve and adverse prognosis in patients with systemic inflammatory disorders","volume":"14","author":"Weber","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.hfc.2025.01.002_bib51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2009.02.069","article-title":"Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve","volume":"54","author":"Herzog","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2025.01.002_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.114.011939","article-title":"Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/eurheartj\/ehz389","article-title":"Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization","volume":"41","author":"Patel","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.hfc.2025.01.002_bib55","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2013.279208","article-title":"Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial","volume":"310","author":"Abdallah","year":"2013","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.hfc.2025.01.002_bib56","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/CIRCULATIONAHA.110.978247","article-title":"Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease","volume":"123","author":"Dagenais","year":"2011","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2025.01.002_bib57","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2025.01.002_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2025.01.002_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehx683","article-title":"Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy","volume":"39","author":"Bravo","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2025.01.002_bib61","article-title":"Identification of capillary rarefaction using intracoronary wave intensity analysis with resultant prognostic implications for cardiac allograft patients","author":"Broyd","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hfc.2025.01.002_bib62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCIMAGING.114.002184","article-title":"Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant","volume":"7","author":"Mc Ardle","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.hfc.2025.01.002_bib63","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.hfc.2025.01.002_bib64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib65","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.99.4.475","article-title":"Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin","volume":"99","author":"Guethlin","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2025.01.002_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/00365510701297472","article-title":"Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype","volume":"67","author":"Ilveskoski","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"issue":"19","key":"10.1016\/j.hfc.2025.01.002_bib67","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A\u00a0randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hfc.2025.01.002_bib68","article-title":"Ranolazine in symptomatic diabetic patients without obstructive coronary artery disease: impact on microvascular and diastolic function","volume":"6","author":"Shah","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.hfc.2025.01.002_bib69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2025.01.002_bib70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2025.01.002_bib71","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.hfc.2025.01.002_bib72","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.hfc.2025.01.002_bib73","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.hfc.2025.01.002_bib74","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2025.01.002_bib75","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hfc.2025.01.002_bib76","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2025.01.002_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2025.01.002_bib78","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","author":"Packer","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hfc.2025.01.002_bib79","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jcmg.2024.05.022","article-title":"The impact of bariatric surgery on coronary microvascular function assessed using automated quantitative perfusion CMR","volume":"17","author":"Crane","year":"2024","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:05:48Z","timestamp":1750302348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713625000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1551713625000029"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2025.01.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary Microvascular Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}